Aquablation in Benign Prostatic Hyperplasia in Canada

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

25 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-10-09

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To document the clinical outcome of Aquablation therapy for BPH patient in Canadian cohort.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

UK Post-market Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue

NCT04658056

Benign Prostatic Hyperplasia Lower Urinary Tract Symptoms

UNKNOWN

Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)

NCT02505919

Benign Prostatic Hyperplasia (BPH)

COMPLETED NA

Waterjet Prostate Ablation

NCT03938194

Benign Prostatic Hyperplasia

TERMINATED NA

Global Post-Market Registry Using Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue

NCT02974751

BPH

UNKNOWN

PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs

NCT06051942

Benign Prostatic Hyperplasia Localized Prostate Cancer

ACTIVE_NOT_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients will be followed up for 3 years as standard of care.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Urologic Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Aquablation

Intervention Type PROCEDURE

Aquablation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Aquablation

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Primary diagnosis of Benign Prostate Hypertrophy (BPH)
* Male subjects of ≥ 18 years of age
* Candidate for Aquablation therapy as per clinical decision of Investigator
* Willing and able to accurately complete questionnaires
* Willing and able to provide signed and dated informed consent

Exclusion Criteria

* Characteristics indicating a poor compliance with study protocol requirements.
* Disease or other health condition that is not suitable for this study.
* Unable or unwilling to provide signed informed consent.

Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No